THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...
Vous n'êtes pas connecté
Obesity medication Zepbound will be available to buy in 2.5-milligram and 5-milligram single-dose vials on manufacturer Eli Lilly's telehealth platform, the company has announced.
THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but...
Weight loss jabs could be prescribed to children as young as six after trials found they slashed obesity and tackled other health issues.
TERN stock soars on positive data from the early-stage study of TERN-601 for obesity, showing statistically significant weight reduction compared to...
LEHI, Utah., Sept. 12, 2024. Biolexis Therapeutics, a biopharmaceutical company pioneering next-generation weight loss treatments, today announced the...
TUESDAY, Sept. 3, 2024 -- Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health. But they...
AngloGold Ashanti to Buy Centamin for US$2.5 Billion, Creating Fourth Largest Gold Company AngloGold Ashanti (NYSE:AU,JSE:ANG) has announced a US$2.5...
AngloGold Ashanti to Buy Centamin for US$2.5 Billion, Creating Fourth Largest Gold Company AngloGold Ashanti (NYSE:AU,JSE:ANG) has announced a US$2.5...